ホームページ Stem Cells & Wnt Stemness kinase

Stemness kinase

Stemness kinase製品

  • All (2)
  • Stemness kinase阻害剤 (1)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
EMBO J, 2025, 44(13):3645-3668
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
F1339New LIN28A Antibody [A20G22]
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
EMBO J, 2025, 44(13):3645-3668
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
F1339New LIN28A Antibody [A20G22]
united states